Cencora price to book ratio COR

Market value divided by the book value of the company's net assets, since 2009.

Today, Oct 23, 2026: 20.7×
10-year median: 15.7×
Against its 10-year history: 54th; percentile: 0 is its lowest day, 100 its highest
10-year range: 4.9× to 150×
Peer median: 3.0×

Cencora's price to book ratio is 20.7× as of Oct 23, 2026.

That is above its ten-year median of 15.7×, close to the middle of its last ten years.

Over that time it ranged from 4.9× in May 2020 to 150× in Nov 2022.

The median for 3 medical distribution stocks of a similar size is 3.0×.

Price to book ratio over time

median 15.7×

The dashed line is the 10-year median and the shaded band the middle half of its days.

Open the interactive chart, with overlays and comparisons

Year by year

Year	End of year	Low	High
2026 so far	20.7×	14.8×	46.2×
2025	43.9×	27.9×	76.1×
2024	67.9×	40.3×	84.4×
2023	79.0×	51.6×	138×
2022	150×	53.5×	150×
2021	124×	109×	124×
2020	5.7×	4.9×	6.8×
2019	6.1×	5.0×	6.5×
2018	5.3×	5.2×	11.1×
2017	9.7×	6.4×	9.8×
2016	8.1×	7.3×	31.8×
2015	33.7×	10.1×	33.7×
2014	10.2×	8.5×	81.4×
2013	69.6×	41.9×	69.9×
2012	41.0×	30.9×	41.8×
2011	33.5×	30.1×	37.6×
2010	31.9×	26.4×	32.5×
2009	27.6×	21.7×	27.9×

Against its peers

Companies in Medical - Distribution nearest Cencora's size, closest first, today.

Company	Price to book ratio
CORCencora	20.7×
CAHCardinal Health	n/m
MCKMcKesson	n/m
HSICHenry Schein	3.0×
Peer median	3.0×

What the price to book ratio tells you

Market value divided by the accounting value of the company's net assets. Below 1 means the market values the business at less than what it owns on paper.

Book value misses brands, software and people, so asset-light companies always look expensive on it. Most useful for banks and industrials.

More on Cencora

Valuation data, not investment advice. Prices as of Oct 23, 2026. Reported figures come from the company's filings with the SEC.